EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cells
Article in Biochemical Pharmacology (December 2020)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Biochemical Pharmacology (December 2020)
Article in Journal of Cellular Physiology (May 2019)
Article in Frontiers in Immunology (February 2019)